SEC Filing Summary: India Globalization Capital, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by India Globalization Capital, Inc. (not IGC Pharma, Inc.) on June 1, 2012, covering events occurring on May 29, 2012. The filing addresses a change in the composition of the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance updates and does not contain financial statements or performance metrics.
Material Changes
The primary material change reported is the resignation of Mr. Danny Qing Chang as a director of the Company. Key details include:
- Mr. Chang orally communicated his resignation on May 29, 2012, effective immediately.
- The Board of Directors accepted the resignation on June 1, 2012.
- Mr. Chang was a non-independent director and one of two Class A directors, with a term scheduled to end at the 2014 annual meeting.
- He was not a member of any board committees.
- The resignation was not the result of any disagreements with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. No specific risks or contingencies were disclosed beyond the standard disclosure regarding the director's departure.
Key Facts for Investor Verification
- Verify the current composition of the Board of Directors following Mr. Chang's departure.
- Confirm whether the Company intends to appoint a replacement director to fill the vacancy.
- Review the attached Press Release (Exhibit 99.1) for any additional context regarding the resignation.
- Note that the registrant name is India Globalization Capital, Inc., distinct from the query's reference to IGC Pharma, Inc.